​​​​​​​​​​​​​​​​In order to sell a medicinal product in Norway, the medicinal product must have a marketing authorisation (MA) issued by the Norwegian Medicines Agency (NoMA).

Parallel import of medicinal products to Norway takes place when a medicinal product with a valid marketing authorisation in an EU/EEA country, is parallel imported to Norway and placed on the Norwegian market in competition with a directly imported medicinal product with similar composition and a valid marketing authorisation in Norway.

Publisert: 07.06.2021

​Fant du det du lette etter?